M.A.M. Berends

797 total citations
19 papers, 539 citations indexed

About

M.A.M. Berends is a scholar working on Immunology, Dermatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M.A.M. Berends has authored 19 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 9 papers in Dermatology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M.A.M. Berends's work include Psoriasis: Treatment and Pathogenesis (16 papers), Dermatology and Skin Diseases (9 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). M.A.M. Berends is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (16 papers), Dermatology and Skin Diseases (9 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). M.A.M. Berends collaborates with scholars based in Netherlands, United States and Türkiye. M.A.M. Berends's co-authors include E.M.G.J. de Jong, P.C.M. van de Kerkhof, R.J.B. Driessen, Joost P.H. Drenth, Martijn G.H. van Oijen, J. Han van Krieken, P.P.M. van Lümig, J.B.M. Boezeman, M.I.A. Koetsier and M.D. Njoo and has published in prestigious journals such as Journal of Hepatology, British Journal of Dermatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

M.A.M. Berends

19 papers receiving 519 citations

Peers

Countries citing papers authored by M.A.M. Berends

Since Specialization

Citations

This map shows the geographic impact of M.A.M. Berends's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A.M. Berends with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A.M. Berends more than expected).

Fields of papers citing papers by M.A.M. Berends

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A.M. Berends. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A.M. Berends. The network helps show where M.A.M. Berends may publish in the future.

Co-authorship network of co-authors of M.A.M. Berends

This figure shows the co-authorship network connecting the top 25 collaborators of M.A.M. Berends. A scholar is included among the top collaborators of M.A.M. Berends based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A.M. Berends. M.A.M. Berends is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial 2022 ·Journal of Dermatological Treatment ·(unknown), Sophie E. Berends, Hans Groenewoud, Ron A. A. Mathôt, (unknown), J.M. Mommers, Paul M. Ossenkoppele, M.I.A. Koetsier, M.A.M. Berends, Annick de Vries, P.C.M. van de Kerkhof, Alfons A den Broeder, E.M.G.J. de Jong, J. M. P. A. van den Reek	8
2	Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis 2020 ·JAMA Dermatology ·(unknown), J.M.P.A. van den Reek, Alfons A den Broeder, Lieke J. van Vugt, Marisol E. Otero, M.D. Njoo, J.M. Mommers, Paul M. Ossenkoppele, M.I.A. Koetsier, M.A.M. Berends, P.C.M. van de Kerkhof, Hans Groenewoud, Wietske Kievit, E.M.G.J. de Jong	34
3	Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry 2019 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), J.M.P.A. van den Reek, J.M.M. Groenewoud, Marisol E. Otero, M.D. Njoo, Paul M. Ossenkoppele, J.M. Mommers, M.I.A. Koetsier, M.A.M. Berends, W.P. Arnold, B Peters, M.P.M. Andriessen, (unknown), A.L.A. Kuijpers, E.M.G.J. de Jong	33
4	The journey of adult psoriasis patients towards biologics: past and present ‐ Results from the BioCAPTURE registry 2017 ·Journal of the European Academy of Dermatology and Venereology ·J. M. P. A. van den Reek, Marieke M.B. Seyger, P.P.M. van Lümig, R.J.B. Driessen, (unknown), M.A.M. Berends, P.C.M. van de Kerkhof, E.M.G.J. de Jong	21
5	Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t 2016 ·British Journal of Dermatology ·Jeffrey Zweegers, J.M.P.A. van den Reek, P.C.M. van de Kerkhof, Marisol E. Otero, A.L.A. Kuijpers, M.I.A. Koetsier, W.P. Arnold, M.A.M. Berends, (unknown), Paul M. Ossenkoppele, M.D. Njoo, J.M. Mommers, P.P.M. van Lümig, R.J.B. Driessen, Wietske Kievit, E.M.G.J. de Jong	60
6	Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry 2016 ·British Journal of Dermatology ·Jeffrey Zweegers, J.M.M. Groenewoud, J. M. P. A. van den Reek, Marisol E. Otero, P.C.M. van de Kerkhof, R.J.B. Driessen, P.P.M. van Lümig, M.D. Njoo, Paul M. Ossenkoppele, J.M. Mommers, M.I.A. Koetsier, W.P. Arnold, M.P.M. Andriessen, A.L.A. Kuijpers, M.A.M. Berends, Wietske Kievit, E.M.G.J. de Jong	38
7	Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort 2016 ·British Journal of Dermatology ·Jeffrey Zweegers, (unknown), P.C.M. van de Kerkhof, J.M.P.A. van den Reek, Marisol E. Otero, (unknown), A.L.A. Kuijpers, M.I.A. Koetsier, W.P. Arnold, M.A.M. Berends, (unknown), (unknown), M.D. Njoo, J.M. Mommers, P.P.M. van Lümig, R.J.B. Driessen, Wietske Kievit, E.M.G.J. de Jong	41
8	Safety of treatment with biologics for psoriasis in daily practice: 5‐year data 2011 ·Journal of the European Academy of Dermatology and Venereology ·P.P.M. van Lümig, R.J.B. Driessen, M.A.M. Berends, J.B.M. Boezeman, P.C.M. van de Kerkhof, E.M.G.J. de Jong	30
9	Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies 2008 ·British Journal of Dermatology ·(unknown), (unknown), P.C.M. van de Kerkhof, M.A.M. Berends, (unknown), (unknown), J.B.M. Boezeman, Marieke M.B. Seyger, E.M.G.J. de Jong	9
10	Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome 2008 ·British Journal of Dermatology ·R.J.B. Driessen, M.A.M. Berends, J.B.M. Boezeman, P.C.M. van de Kerkhof, E.M.G.J. de Jong	21
11	Good clinical response to anti‐psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T‐cell subsets: A pilot study 2008 ·Journal of Dermatological Treatment ·(unknown), E.M.G.J. de Jong, M.A.M. Berends, Marieke M.B. Seyger, P.E.J. van Erp, P.C.M. van de Kerkhof	1
12	Dermatologists’ Adherence to the Guideline of the Dutch Society of Dermatology and Venereology with Respect to the Treatment with Methotrexate for Severe Chronic Plaque Psoriasis: Results from a Dutch Survey 2007 ·Dermatology ·M.A.M. Berends, E.M.G.J. de Jong, P.C.M. van de Kerkhof, M. Gerritsen	9
13	Biochemical and biophysical assessment of MTX‐induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan^® predicts the absence of significant liver fibrosis 2007 ·Liver International ·M.A.M. Berends, (unknown), E.M.G.J. de Jong, J. Han van Krieken, Robert J. de Knegt, Martijn G.H. van Oijen, P.C.M. van de Kerkhof, Joost P.H. Drenth	66
14	Reliability of the Roenigk Classification of Liver Damage After Methotrexate Treatment for Psoriasis 2007 ·Archives of Dermatology ·M.A.M. Berends, Martijn G.H. van Oijen, (unknown), P.C.M. van de Kerkhof, Joost P.H. Drenth, J. Han van Krieken, E.M.G.J. de Jong	32
15	Etanercept and efalizumab treatment for high‐need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice 2007 ·Journal of Dermatological Treatment ·M.A.M. Berends, R.J.B. Driessen, (unknown), J.B.M. Boezeman, P.C.M. van de Kerkhof, E.M.G.J. de Jong	24
16	Rare localisation of air. 2007 ·PubMed ·M.A.M. Berends, (unknown), (unknown)	1
17	Liver injury in long‐term methotrexate treatment in psoriasis is relatively infrequent 2006 ·Alimentary Pharmacology & Therapeutics ·M.A.M. Berends, (unknown), E.M.G.J. de Jong, P.C.M. van de Kerkhof, Martijn G.H. van Oijen, J. Han van Krieken, Joost P.H. Drenth	57
18	680 Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent 2006 ·Journal of Hepatology ·M.A.M. Berends, (unknown), P.C.M. van de Kerkhof, E.M.G.J. de Jong, (unknown), Joost P.H. Drenth	6
19	The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T‐cell subsets in chronic plaque psoriasis 2004 ·Experimental Dermatology ·W.H.P.M. Vissers, M.A.M. Berends, Leon Muys, P.E.J. van Erp, E.M.G.J. de Jong, P.C.M. van de Kerkhof	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact